Clinical trials
Phase 3 Proteinuria trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Bayer | 2 |
| Chiesi Farmaceutici S.p.A. | 2 |
| Albert Einstein College of Medicine | 1 |
| George W. Burke | 1 |
| Mayo Clinic | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Omeros Corporation | 1 |
| Protalix | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Proteinuria | 17 |
| Glomerulonephritis, IGA | 6 |
| Renal Insufficiency, Chronic | 5 |
| Fabry Disease | 3 |
| Kidney Diseases | 2 |
| Glomerulosclerosis, Focal Segmental | 1 |
| IgA Vasculitis | 1 |
| Nephrosis | 1 |
| Nephrosis, Lipoid | 1 |
| Osteoporosis | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.